161 related articles for article (PubMed ID: 30445206)
1. DNp73-induced degradation of tyrosinase links depigmentation with EMT-driven melanoma progression.
Fürst K; Steder M; Logotheti S; Angerilli A; Spitschak A; Marquardt S; Schumacher T; Engelmann D; Herchenröder O; Rupp RAW; Pützer BM
Cancer Lett; 2019 Feb; 442():299-309. PubMed ID: 30445206
[TBL] [Abstract][Full Text] [Related]
2. Aberrant retention of tyrosinase in the endoplasmic reticulum mediates accelerated degradation of the enzyme and contributes to the dedifferentiated phenotype of amelanotic melanoma cells.
Halaban R; Cheng E; Zhang Y; Moellmann G; Hanlon D; Michalak M; Setaluri V; Hebert DN
Proc Natl Acad Sci U S A; 1997 Jun; 94(12):6210-5. PubMed ID: 9177196
[TBL] [Abstract][Full Text] [Related]
3. DNp73 exerts function in metastasis initiation by disconnecting the inhibitory role of EPLIN on IGF1R-AKT/STAT3 signaling.
Steder M; Alla V; Meier C; Spitschak A; Pahnke J; Fürst K; Kowtharapu BS; Engelmann D; Petigk J; Egberts F; Schäd-Trcka SG; Gross G; Nettelbeck DM; Niemetz A; Pützer BM
Cancer Cell; 2013 Oct; 24(4):512-27. PubMed ID: 24135282
[TBL] [Abstract][Full Text] [Related]
4. p73 and IGF1R Regulate Emergence of Aggressive Cancer Stem-like Features via miR-885-5p Control.
Meier C; Hardtstock P; Joost S; Alla V; Pützer BM
Cancer Res; 2016 Jan; 76(2):197-205. PubMed ID: 26554827
[TBL] [Abstract][Full Text] [Related]
5. p73 induction by Abrus agglutinin facilitates Snail ubiquitination to inhibit epithelial to mesenchymal transition in oral cancer.
Sinha N; Meher BR; Naik PP; Panda PK; Mukhapadhyay S; Maiti TK; Bhutia SK
Phytomedicine; 2019 Mar; 55():179-190. PubMed ID: 30668428
[TBL] [Abstract][Full Text] [Related]
6. Partially purified components of Nardostachys chinensis suppress melanin synthesis through ERK and Akt signaling pathway with cAMP down-regulation in B16F10 cells.
Jang JY; Kim HN; Kim YR; Choi WY; Choi YH; Shin HK; Choi BT
J Ethnopharmacol; 2011 Oct; 137(3):1207-14. PubMed ID: 21816215
[TBL] [Abstract][Full Text] [Related]
7. Exploiting tyrosinase expression and activity in melanocytic tumors: quercetin and the central role of p53.
Vargas AJ; Sittadjody S; Thangasamy T; Mendoza EE; Limesand KH; Burd R
Integr Cancer Ther; 2011 Dec; 10(4):328-40. PubMed ID: 21196432
[TBL] [Abstract][Full Text] [Related]
8. Tyrosinase-related proteins suppress tyrosinase-mediated cell death of melanocytes and melanoma cells.
Rad HH; Yamashita T; Jin HY; Hirosaki K; Wakamatsu K; Ito S; Jimbow K
Exp Cell Res; 2004 Aug; 298(2):317-28. PubMed ID: 15265682
[TBL] [Abstract][Full Text] [Related]
9. N-(3,5-dimethylphenyl)-3-methoxybenzamide (A(3)B(5)) targets TRP-2 and inhibits melanogenesis and melanoma growth.
Lee EJ; Lee YS; Hwang S; Kim S; Hwang JS; Kim TY
J Invest Dermatol; 2011 Aug; 131(8):1701-9. PubMed ID: 21525883
[TBL] [Abstract][Full Text] [Related]
10. Pigment content of cultured human melanocytes does not correlate with tyrosinase message level.
Naeyaert JM; Eller M; Gordon PR; Park HY; Gilchrest BA
Br J Dermatol; 1991 Oct; 125(4):297-303. PubMed ID: 1720016
[TBL] [Abstract][Full Text] [Related]
11. Anti-melanogenic effects of Aster spathulifolius extract in UVB-exposed C57BL/6J mice and B16F10 melanoma cells through the regulation of MAPK/ERK and AKT/GSK3β signalling.
Hwang GY; Choung SY
J Pharm Pharmacol; 2016 Apr; 68(4):503-13. PubMed ID: 26993057
[TBL] [Abstract][Full Text] [Related]
12. Ferritin light chain down-modulation generates depigmentation in human metastatic melanoma cells by influencing tyrosinase maturation.
Maresca V; Flori E; Cardinali G; Briganti S; Lombardi D; Mileo AM; Paggi MG; Picardo M
J Cell Physiol; 2006 Mar; 206(3):843-8. PubMed ID: 16252260
[TBL] [Abstract][Full Text] [Related]
13. Okadaic acid suppresses melanogenesis via proteasomal degradation of tyrosinase.
Jeong HS; Yun HY; Baek KJ; Kwon NS; Park KC; Kim DS
Biol Pharm Bull; 2013; 36(9):1503-8. PubMed ID: 23995664
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory effect of Gastrodia elata extract on melanogenesis in HM3KO melanoma cells.
Kim HJ; Lee JH; Shin MK; Hyun Leem K; Kim YJ; Lee MH
J Cosmet Sci; 2013; 64(2):89-98. PubMed ID: 23578832
[TBL] [Abstract][Full Text] [Related]
15. The antimycotic agent clotrimazole inhibits melanogenesis by accelerating ERK and PI3K-/Akt-mediated tyrosinase degradation.
Chung BY; Kim SY; Jung JM; Won CH; Choi JH; Lee MW; Chang SE
Exp Dermatol; 2015 May; 24(5):386-8. PubMed ID: 25690686
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effects of 16-hydroxy-9-oxo-10E,12E,14E-octadecatrienoic acid (Corchorifatty acid B) isolated from Melissa officinalis Linné on melanogenesis.
Fujita H; Hongo M; Mochizuki M; Yokoyama K; Tanaka Y
Exp Dermatol; 2011 May; 20(5):420-4. PubMed ID: 21410768
[TBL] [Abstract][Full Text] [Related]
17. Detection of tyrosinase mRNA from the blood of melanoma patients.
Stevens GL; Scheer WD; Levine EA
Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):293-6. PubMed ID: 8722221
[TBL] [Abstract][Full Text] [Related]
18. Attenuation of melanogenesis by Nymphaea nouchali (Burm. f) flower extract through the regulation of cAMP/CREB/MAPKs/MITF and proteasomal degradation of tyrosinase.
Alam MB; Ahmed A; Motin MA; Kim S; Lee SH
Sci Rep; 2018 Sep; 8(1):13928. PubMed ID: 30224716
[TBL] [Abstract][Full Text] [Related]
19. Value of dopachrome tautomerase detection in the assessment of melanocytic tumors.
Filimon A; Zurac SA; Milac AL; Sima LE; Petrescu SM; Negroiu G
Melanoma Res; 2014 Jun; 24(3):219-36. PubMed ID: 24709887
[TBL] [Abstract][Full Text] [Related]
20. BMP-2 stimulates tyrosinase gene expression and melanogenesis in differentiated melanocytes.
Bilodeau ML; Greulich JD; Hullinger RL; Bertolotto C; Ballotti R; Andrisani OM
Pigment Cell Res; 2001 Oct; 14(5):328-36. PubMed ID: 11601654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
